822
Views
23
CrossRef citations to date
0
Altmetric
Review

Novel drug targets for idiopathic pulmonary fibrosis

, , &
Pages 393-405 | Received 23 Dec 2015, Accepted 05 Feb 2016, Published online: 26 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paolo Spagnolo, Roberto Tonelli, Anna Valeria Samarelli, Gioele Castelli, Elisabetta Cocconcelli, Simone Petrarulo, Stefania Cerri, Nicol Bernardinello, Enrico Clini, Marina Saetta & Elisabetta Balestro. (2022) The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance. Expert Opinion on Therapeutic Targets 26:7, pages 617-631.
Read now
Giacomo Sgalla, Mariachiara Flore, Matteo Siciliano & Luca Richeldi. (2020) Antibody-based therapies for idiopathic pulmonary fibrosis. Expert Opinion on Biological Therapy 20:7, pages 779-786.
Read now
Jing Tang, Jianming Li, Guo Li, Haitao Zhang, Ling Wang, Dai Li & Jinsong Ding. (2017) Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis. International Journal of Nanomedicine 12, pages 6687-6704.
Read now

Articles from other publishers (20)

Sheiphali Gandhi, Roberto Tonelli, Margaret Murray, Anna Valeria Samarelli & Paolo Spagnolo. (2023) Environmental Causes of Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences 24:22, pages 16481.
Crossref
Ying Xu, Yan Xia, Qinhui Liu, Xiandan Jing, Qin Tang, Jinhang Zhang, Qingyi Jia, Zijing Zhang, Jiahui Li, Jiahao Chen, Yimin Xiong, Yanping Li & Jinhan He. (2023) Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites. Journal of Pharmaceutical Analysis.
Crossref
Mohammadhossein Dabaghi, Mabel Barreiro Carpio, Neda Saraei, Jose Manuel Moran-Mirabal, Martin R. Kolb & Jeremy A. Hirota. (2023) A roadmap for developing and engineering in vitro pulmonary fibrosis models . Biophysics Reviews 4:2.
Crossref
Isaac Hsia, Mohammadnabi Asmani & Ruogang Zhao. (2023) Predicting the preclinical efficacy of anti-fibrosis agents using a force-sensing fibrosis on chip system. Biosensors and Bioelectronics 228, pages 115194.
Crossref
Mahbub Hasan, Nidhan Chandra Paul, Shamrat Kumar Paul, Abu Saim Mohammad Saikat, Hafeza Akter, Manoj Mandal & Sang-Suk Lee. (2022) Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis. Molecules 27:5, pages 1481.
Crossref
Alessandro Marchioni, Roberto Tonelli, Alessandro Andreani, Gaia Francesca Cappiello, Matteo Fermi, Fabiana Trentacosti, Ivana Castaniere, Riccardo Fantini, Luca Tabbì, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi, Antonio Moretti, Serena Baroncini, Anna Valeria Samarelli, Massimo Pinelli, Giorgio De Santis, Alessandro Stefani, Daniele Marchioni, Francesco Mattioli & Enrico Clini. (2022) Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults. International Journal of Molecular Sciences 23:5, pages 2421.
Crossref
Anna Valeria Samarelli, Valentina Masciale, Beatrice Aramini, Georgina Pamela Coló, Roberto Tonelli, Alessandro Marchioni, Giulia Bruzzi, Filippo Gozzi, Dario Andrisani, Ivana Castaniere, Linda Manicardi, Antonio Moretti, Luca Tabbì, Giorgia Guaitoli, Stefania Cerri, Massimo Dominici & Enrico Clini. (2021) Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development. International Journal of Molecular Sciences 22:22, pages 12179.
Crossref
Yue Xi, Yanping Li, Pengfei Xu, Sihan LiZhengsheng LiuHung-chun Tung, Xinran Cai, Jingyuan Wang, Haozhe HuangMenglin Wang, Meishu XuSongrong Ren, Song Li, Min Zhang, Yong J. Lee, Leaf Huang, Da Yang, Jinhan HeZhiying Huang & Wen Xie. (2021) The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1. Science Advances 7:36.
Crossref
Anna Valeria Samarelli, Roberto Tonelli, Irene Heijink, Aina Martin Medina, Alessandro Marchioni, Giulia Bruzzi, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Linda Manicardi, Antonio Moretti, Stefania Cerri, Riccardo Fantini, Luca Tabbì, Chiara Nani, Ilenia Mastrolia, Daniel J. Weiss, Massimo Dominici & Enrico Clini. (2021) Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution. Frontiers in Pharmacology 12.
Crossref
Alessandro Marchioni, Roberto Tonelli, Stefania Cerri, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi, Antonio Moretti, Jacopo Demurtas, Serena Baroncini, Alessandro Andreani, Gaia Francesca Cappiello, Stefano Busani, Riccardo Fantini, Luca Tabbì, Anna Valeria Samarelli & Enrico Clini. (2021) Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung. International Journal of Molecular Sciences 22:12, pages 6443.
Crossref
Roberto Tonelli, Alessandro Marchioni, Luca Tabbì, Riccardo Fantini, Stefano Busani, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi, Jacopo Demurtas, Alessandro Andreani, Gaia Francesca Cappiello, Anna Valeria Samarelli & Enrico Clini. (2021) Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario. Journal of Clinical Medicine 10:5, pages 975.
Crossref
Elisabetta Cocconcelli, Roberto Tonelli, Gianluca Abbati, Alessandro Marchioni, Ivana Castaniere, Filippo Pelizzaro, Francesco Paolo Russo, Alberto Vegetti, Elisabetta Balestro, Antonello Pietrangelo, Luca Richeldi, Fabrizio Luppi, Paolo Spagnolo, Enrico Clini & Stefania Cerri. (2020) Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis. Internal and Emergency Medicine 16:2, pages 349-357.
Crossref
Ángel González. (2020) The Therapy of Pulmonary Fibrosis in Paracoccidioidomycosis: What Are the New Experimental Approaches?. Journal of Fungi 6:4, pages 217.
Crossref
Somnath Mazumder, Mukta Barman, Uday Bandyopadhyay & Samik Bindu. (2020) Sirtuins as endogenous regulators of lung fibrosis: A current perspective. Life Sciences 258, pages 118201.
Crossref
Anne-Ulrike Trendelenburg. 2020. Anti-fibrotic Drug Discovery. Anti-fibrotic Drug Discovery 1 36 .
Yoon Mee Yang, Mazen Noureddin, Cheng Liu, Koichiro Ohashi, So Yeon Kim, Divya Ramnath, Elizabeth E. Powell, Matthew J. Sweet, Yoon Seok Roh, I-Fang Hsin, Nan Deng, Zhenqiu Liu, Jiurong Liang, Edward Mena, Daniel Shouhed, Robert F. Schwabe, Dianhua Jiang, Shelly C. Lu, Paul W. Noble & Ekihiro Seki. (2019) Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Science Translational Medicine 11:496, pages eaat9284.
Crossref
Aswin Sundarakrishnan, Heather Zukas, Jeannine Coburn, Brian T. Bertini, Zhiyi Liu, Irene Georgakoudi, Lauren Baugh, Queeny Dasgupta, Lauren D. Black & David L. Kaplan. (2019) Bioengineered in Vitro Tissue Model of Fibroblast Activation for Modeling Pulmonary Fibrosis . ACS Biomaterials Science & Engineering 5:5, pages 2417-2429.
Crossref
Kentaro Fujiwara, Tetsu Kobayashi, Hajime Fujimoto, Hiroki Nakahara, Corina N. D'Alessandro-Gabazza, Josephine A. Hinneh, Yoshinori Takahashi, Taro Yasuma, Kota Nishihama, Masaaki Toda, Masahiro Kajiki, Yoshiyuki Takei, Osamu Taguchi & Esteban C. Gabazza. (2017) Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin. The American Journal of Pathology 187:10, pages 2312-2322.
Crossref
Daniele Magnini, Giuliano Montemurro, Bruno Iovene, Linda Tagliaboschi, Rafael Emanuele Gerardi, Erminia Lo Greco, Teresa Bruni, Alessio Fabbrizzi, Francesco Lombardi & Luca Richeldi. (2017) Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies. Respiration 93:6, pages 379-395.
Crossref
Fernando J Martinez, Alison Chisholm, Harold R Collard, Kevin R Flaherty, Jeffrey Myers, Ganesh Raghu, Simon L F Walsh, Eric S White & Luca Richeldi. (2017) The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. The Lancet Respiratory Medicine 5:1, pages 61-71.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.